Invention Grant
US09051315B2 Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
有权
咪唑并吡啶作为多靶向激酶抑制的新型支架
- Patent Title: Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition
- Patent Title (中): 咪唑并吡啶作为多靶向激酶抑制的新型支架
-
Application No.: US12906681Application Date: 2010-10-18
-
Publication No.: US09051315B2Publication Date: 2015-06-09
- Inventor: Nwe Y. Ba-maung , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Megumi Kawai , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang
- Applicant: Nwe Y. Ba-maung , Richard F. Clark , Scott A. Erickson , Steve D. Fidanze , Megumi Kawai , Robert A. Mantei , George S. Sheppard , Bryan K. Sorensen , Gary T. Wang
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Glen J. Gesicki
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K31/535 ; A61K31/497 ; C07D223/14 ; C07D413/04 ; C07D239/02 ; C07D471/04
Abstract:
Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
Public/Granted literature
- US20110124632A1 IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION Public/Granted day:2011-05-26
Information query
